| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Benign ethnic neutropenia
|
Atallah-Yunes, Suheil Albert
|
|
2019
|
37 |
C |
p.
|
article
|
| 2 |
Cellular therapy for acute myeloid Leukemia – Current status and future prospects
|
Hansrivijit, Panupong
|
|
2019
|
37 |
C |
p.
|
article
|
| 3 |
Challenges of blood transfusions in β-thalassemia
|
Shah, Farrukh T.
|
|
2019
|
37 |
C |
p.
|
article
|
| 4 |
From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?
|
Bewersdorf, Jan Philipp
|
|
2019
|
37 |
C |
p.
|
article
|
| 5 |
Genotype-phenotype associations in Fanconi anemia: A literature review
|
Fiesco-Roa, Moisés O.
|
|
2019
|
37 |
C |
p.
|
article
|
| 6 |
Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?
|
Margelidon-Cozzolino, Victor
|
|
2019
|
37 |
C |
p.
|
article
|
| 7 |
Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings
|
Kannan, Meganathan
|
|
2019
|
37 |
C |
p.
|
article
|
| 8 |
Sickle cell disease: Clinical presentation and management of a global health challenge
|
Houwing, M.E.
|
|
2019
|
37 |
C |
p.
|
article
|
| 9 |
Thalassemia and malignancy: An emerging concern?
|
Hodroj, Mohammad Hassan
|
|
2019
|
37 |
C |
p.
|
article
|
| 10 |
Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?
|
Aldoss, Ibrahim
|
|
2019
|
37 |
C |
p.
|
article
|
| 11 |
Update on mutations in the HIF: EPO pathway and their role in erythrocytosis
|
Lappin, Terence R.
|
|
2019
|
37 |
C |
p.
|
article
|
| 12 |
Use of novel therapies in the treatment of light chain amyloidosis
|
Varga, Cindy
|
|
2019
|
37 |
C |
p.
|
article
|
Journal description